Company attributes
Industry
Location
B2X
Pitchbook URL
Number of Employees (Ranges)
11 – 50
Full Address
Medicon Village 223 81 Lund Sweden
Investors
Founded Date
2016
0Total Funding Amount (USD)
690,000
Latest Funding Round Date
November 2016
Latest Funding Type
Other attributes
Company Operating Status
Active
Merozyne Therapeutics was established to develop a pharmacological treatment for MDC1A. MDC1A is a rare and severe form of muscular dystrophy caused by mutations in the gene encoding the protein laminin.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
